[1] [1] XIA C F, DONG X S, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590.

[2] [2] BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.

[3] [3] CHEN D W, LANG B H H, MCLEOD D S A, et al. Thyroid cancer[J]. Lancet, 2023, 401(10387): 1531-1544.

[5] [5] CARRILLO J F, VOLPI E M. Editorial: Recent advances in papillary thyroid carcinoma: lymph node metastasis[J]. Front Endocrinol (Lausanne), 2022, 13: 1084034.

[6] [6] ASIMAKOPOULOS P, SHAHA A R, NIXON I J, et al. Management of the neck in well-differentiated thyroid cancer[J]. Curr Oncol Rep, 2020, 23(1): 1.

[7] [7] BAE S Y, YANG J H, CHOI M Y, et al. Right paraesophageal lymph node dissection in papillary thyroid carcinoma[J]. Ann Surg Oncol, 2012, 19(3): 996-1000.

[9] [9] CARTY S E, COOPER D S, DOHERTY G M, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer[J]. Thyroid, 2009, 19(11): 1153-1158.

[10] [10] PATEL K N, YIP L, LUBITZ C C, et al. The American association of endocrine surgeons guidelines for the definitive surgical management of thyroid disease in adults[J]. Ann Surg, 2020, 271(3): e21-e93.

[11] [11] HAUGEN B R, ALEXANDER E K, BIBLE K C, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.

[12] [12] SHAO L, SUN W, ZHANG H, et al. Risk factors for right paraesophageal lymph node metastasis in papillary thyroid carcinoma: a meta-analysis[J]. Surg Oncol, 2020, 32: 90-98.

[13] [13] DU W, FANG Q G, ZHANG X, et al. Metastasis of CN0 papillary thyroid carcinoma of the isthmus to the lymph node posterior to the right recurrent laryngeal nerve[J]. Front Endocrinol (Lausanne), 2021, 12: 677986.

[14] [14] ZHOU M Q, DUAN Y S, YE B B, et al. Pattern and predictive factors of metastasis in lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne), 2022, 13: 914946.

[15] [15] CHANG H, YOO R N, KIM S M, et al. The clinical significance of the right para-oesophageal lymph nodes in papillary thyroid cancer[J]. Yonsei Med J, 2015, 56(6): 1632-1637.

[16] [16] DONG W W, HORIUCHI K, TOKUMITSU H, et al. Timevarying pattern of mortality and recurrence from papillary thyroid cancer: lessons from a long-term follow-up[J]. Thyroid, 2019, 29(6): 802-808.

[17] [17] KIM D, KWON H K, SHIN S C, et al. Right posterior paratracheal lymph nodes metastasis is one of the predictive factors in right-sided papillary thyroid carcinoma[J]. Surgery, 2019, 166(6): 1154-1159.

[18] [18] SEOK J, RYU C H, PARK S Y, et al. Factors affecting central node metastasis and metastatic lymph node ratio in papillary thyroid cancer[J]. Otolaryngol Head Neck Surg, 2021, 165(4): 519-527.

[19] [19] CHEN L, WU Y H, LEE C H, et al. Prophylactic central neck dissection for papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes: a systematic review and meta-analysis[J]. World J Surg, 2018, 42(9): 2846-2857.

[21] [21] GRODSKI S, CORNFORD L, SYWAK M, et al. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique[J]. ANZ J Surg, 2007, 77(4): 203-208.

[23] [23] SHI Q, XU J Q, FANG J G, et al. Clinical advantages and neuroprotective effects of monitor guided Fang's capillary fascia preservation right RLN dissection technique[J]. Front Endocrinol (Lausanne), 2022, 13: 918741.

[24] [24] DISMUKES J, FAZENDIN J, OBIARINZE R, et al. Prophylactic central neck dissection in papillary thyroid carcinoma: all risks, No reward[J]. J Surg Res, 2021, 264: 230-235.

[25] [25] AHN J H, KWAK J H, YOON S G, et al. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma[J]. Surgery, 2022, 171(1): 182-189.

[26] [26] DOBRINJA C, TROIAN M, CIPOLAT MIS T, et al. Rationality in prophylactic central neck dissection in clinically nodenegative (cN0) papillary thyroid carcinoma: is there anything more to say? A decade experience in a single-center[J]. Int J Surg, 2017, 41(Suppl 1): S40-S47.

[27] [27] ZHANG S T, ZHANG R F, WANG C, et al. Unnecessity of routine dissection of right central lymph nodes in cN0 papillary thyroid carcinoma located at the left thyroid lobe[J]. Front Oncol, 2021, 11: 685708.

[28] [28] ZHAO H Q, LI H H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases[J]. Eur J Radiol, 2019, 112: 14-21.

[30] [30] TESSLER F N, MIDDLETON W D, GRANT E G, et al. Re: ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee[J]. J Am Coll Radiol, 2018, 15(3 Pt A): 381-382.

[31] [31] CHANG W Y, TANG L, LU C W, et al. Shear wave elastography in the evaluation of level Ⅵ lymph nodes in papillary thyroid carcinoma: combined with gray-scale ultrasoundex vivo[J]. BMC Cancer, 2018, 18(1): 1001.

[35] [35] YANG H J, TAO L. Lymph node posterior to the right recurrent laryngeal nerve metastasis in right lobe T1a papillary thyroid carcinoma: a retrospective cohort study[J]. Cancer Control, 2023, 30: 10732748221149819.

[36] [36] LI J B, HE G F, TONG Y F, et al. A novel scoring system for the risk of papillary thyroid cancer metastases in lymph nodes posterior to the right of the recurrent laryngeal nerve[J]. Endocr Pract, 2021, 27(1): 15-20.

[38] [38] ZHANG S, XU C, YANG B, et al. Nomogram combining preoperative ultrasonography with clinical features for predicting lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid cancer[J]. Acta Endocrinol (Buchar), 2022, 18(3): 333-342.

[39] [39] ZOU M, WANG Y H, DONG Y F, et al. Clinical and sonographic features for the preoperative prediction of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma[J]. J Endocrinol Invest, 2020, 43(10): 1511-1517.

[43] [43] LU K N, ZHANG Y, DA J Y, et al. A novel scoring system for predicting the metastases of posterior right recurrent laryngeal nerve lymph node involvement in patients with papillary thyroid carcinoma by preoperative ultrasound[J]. Front Endocrinol (Lausanne), 2021, 12: 738138.

[44] [44] FANG F K, GONG Y, LIAO L Y, et al. Value of contrastenhanced ultrasound for evaluation of cervical lymph node metastasis in papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne), 2022, 13: 812475.

[45] [45] GONG Y, ZUO Z K, TANG K, et al. Multimodal predictive factors of metastasis in lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne), 2023, 14: 1187825.

[46] [46] YE F, GONG Y, TANG K, et al. Contrast-enhanced ultrasound characteristics of preoperative central cervical lymph node metastasis in papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne), 2022, 13: 941905.

[47] [47] HONG Y R, YAN C X, MO G Q, et al. Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases[J]. Sci Rep, 2015, 5: 7748.

[48] [48] JIANG L Q, ZHANG Z J, GUO S Y, et al. Clinical-radiomics nomogram based on contrast-enhanced ultrasound for preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma[J]. Cancers (Basel), 2023, 15(5): 1613.

[49] [49] GRANT E G, KWON D I. Is there a place for lymphatic contrast-enhanced US in thyroid cancer?[J]. Radiology, 2023, 307(4): e230560.

[50] [50] ZHANG Y, LU Y Y, LI W, et al. Lymphatic contrast-enhanced US to improve the diagnosis of cervical lymph node metastasis from thyroid cancer[J]. Radiology, 2023, 307(4): e221265.

[52] [52] LI T T, LI H Z, XUE J P, et al. Shear wave elastography combined with gray-scale ultrasound for predicting central lymph node metastasis of papillary thyroid carcinoma[J]. Surg Oncol, 2021, 36: 1-6.

[55] [55] CHANG L C, ZHANG Y Q, ZHU J L, et al. An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: a multicenter study[J]. Front Endocrinol (Lausanne), 2023, 14: 964074.

[56] [56] ZHANG S J, LIU R J, WANG Y Y, et al. Ultrasound-base radiomics for discerning lymph node metastasis in thyroid cancer: a systematic review and meta-analysis[J]. Acad Radiol, 2024, 31(8): 3118-3130.

[57] [57] SHEN B, ZHOU C, XU C L, et al. Ultrasound-based radiomics for predicting metastasis in the lymph nodes posterior to the right recurrent laryngeal nerve in patients with papillary thyroid cancer[J]. Curr Med Imaging, 2023.

[58] [58] ALABOUSI M, ALABOUSI A, ADHAM S, et al. Diagnostic test accuracy of ultrasonography vs computed tomography for papillary thyroid cancer cervical lymph node metastasis: a systematic review and meta-analysis[J]. JAMA Otolaryngol Head Neck Surg, 2022, 148(2): 107-118.

[61] [61] QU Y, ZHANG H, ZHANG P, et al. Risk factors and the preoperative assessment of right Para-oesophageal lymph node metastasis in right lobe papillary thyroid carcinoma: a case series[J]. Int J Surg, 2017, 42: 123-127.

[65] [65] LEE Y, KIM J H, BAEK J H, et al. Value of CT added to ultrasonography for the diagnosis of lymph node metastasis in patients with thyroid cancer[J]. Head Neck, 2018, 40(10): 2137-2148.

[66] [66] SUH C H, BAEK J H, CHOI Y J, et al. Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis[J]. AJNR Am J Neuroradiol, 2017, 38(1): 154-161.